Anti-SjLLPi1 antibody treatment decreases worm burden in mice 7 days after <i>S. japonicum</i> infection. by Fanyan Chen (3909178)

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

General procedure for the synthesis of B. by Xueqin lu (22250795)

(A) Digital designing of premolar to decrease 1 mm of root surface, (B) 3D printed tooth compared to artificial tooth of model. by Samar S. Alaghbari (21863491)

“…<p>(A) Digital designing of premolar to decrease 1 mm of root surface, (B) 3D printed tooth compared to artificial tooth of model.…”

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Surgery design. by Maria Nadinskaia (22662419)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons. by Sara Hijazi (21656615)

“…<p><b>A.</b> Experimental design to induce juvenile demyelination in PV-tdTomato mice <b>B.…”

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Quinoline-Based DNA Methyltransferase Inhibitors Featuring Basic Side Chains: Design, Synthesis, and Insight in Biochemical and Anticancer Cell Properties by Clemens Zwergel (1307868)

“…The quinoline DNMT inhibitors <b>4</b>–<b>21</b>, incorporating basic chains, were designed, synthesized, and evaluated for their ability to inhibit DNMT1 and DNMT3<i>A</i>/3L by directly measuring DNA methylation. …”

Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain by Jiawen Lang (4288540)

“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [¹⁸F]<b>7a</b>. Cuprizone-fed mice had reduced [¹⁸F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”

Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain by Jiawen Lang (4288540)

“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [¹⁸F]<b>7a</b>. Cuprizone-fed mice had reduced [¹⁸F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”

Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain by Jiawen Lang (4288540)

“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [¹⁸F]<b>7a</b>. Cuprizone-fed mice had reduced [¹⁸F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”

Social change: No decrease in singing rate upon first-time social isolation in the same environment. by Anja T. Zai (9225852)

Task design for measurement of pupillary response. by Tomoe Hayakawa (20978784)

Subjects: